Logo Medical XPRT
Companies
Products
Services
Software
Training
Applications
Sign in
List your business
Oxford Brain Diagnostics Ltd.
About
  2. Companies
  3. Oxford Brain Diagnostics Ltd.
  4. Products
Refine by
Families
3 products found

Oxford Brain Diagnostics Ltd. products

Pharma/Biotech

Track AD - Cortical Disarray Measurement (CDM) Technology

We can provide longitudinal patient results based on changes across baseline and time points in accordance with your clinical trial protocol. Grey matter quality changes can also be provided in brain visualisations over multiple time periods. We can provide our results based on whole brain, brain regions and even sub regions if required.

Select AD - Cortical Disarray Measurement (CDM) Technology

Using CDM® we will optimise patient selection, combine other clinical and patient demographics, and positively impact trial costs and performance. CDM® can estimate a patient’s pathology disease stage using grey matter quality. We provide a likelihood that a patient will progress to the next stage of disease within the next few years.

Technology

Cortical Disarray Measurement Technology

The challenge: Dementia - A Global Healthcare Crisis. Our breakthrough technology is helping us to rethink the way brain health is assessed.